All companies
Visit website
NovaXS Biotech Corp.
OperatingNovaXS Biotech Corp
Healthcare · Biotech · Founded 2021
Woman-founded
Needle-free self-injection technology | Ease of use, panless, better care
Valuation cap ⓘ
$14.0M
As of Feb 2023 · from NovaXS Biotech Corp. Crowd SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$114,193
Across 1 round since 2022
Latest share price
$1.00
NovaXS Biotech Corp. Crowd SAFE 1 offering price
Financials
FY2020–FY2022 · from SEC filings · hover any figure for its source$0
2020
$0
−$62K
2021
$0
−$441K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
Income statement
Revenue
$0
$0
$0
Cost of goods sold
$0
$0
$0
Net income
$0
-$62,494
-$441,043
Taxes paid
$0
$0
$656
Balance sheet
Cash
$0
$297,216
$281,066
Accounts receivable
$0
$0
$0
Total assets
$0
$297,216
$667,325
Short-term debt
$0
$7,872
$26,880
Long-term debt
$0
$290,000
$1,043,593
Total liabilities
$0
$297,872
$1,070,474
Other
Headcount
—
5
0
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$14.0M
Valuation cap
NovaXS Biotech Corp. Crowd SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $114.2K / $1.2MInvestors 231Valuation cap $14M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 4 annual reports (FY2022–FY2025)
231 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001946145Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.